tenders

Celltrion said Thursday that the company’s three oncology biosimilar products — Herzuma, Truxima and Vegzelma — are making their foray into key European markets after winning multiple bids there. Celltrion secured bids in France to supply its cancer-fighting biosimilars to five regional drug purchasing organizations for public hospitals. Both Herzuma and Vegzelma will be supplied […]